In December 2024, NICE recommended the use of tirzepatide (Mounjaro), alongside semaglutide (Wegovy) and liraglutide (Saxenda), for the treatment of weight-related comorbidities.10 NICE recommended these drugs alongside diet and exercise, yet many patients lack structured programs offering nutritional, behavioural, and psychological support
They come with a US Boxed Warning of a risk of thyroid C-cell tumors and medullary thyroid carcinoma and are contraindicated in patients with multiple endocrine neoplasia syndrome type 2
The peptide's effects on multiple receptor subtypes account for its range of biological activities observed in research settings
EXAMPLES: Andarine, Ostarine SIDE EFFECTS: Testicular shrinkage, liver injury and failure, infertility, sexual dysfunction, sleep disturbances, and increased risk of heart attack and stroke
But its more than that
MEDVi's three-entity structure - platform, independent clinicians, and licensed pharmacies - is consistent with common telehealth models